Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function.

@article{Albera2016EfficacyOP,
  title={Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function.},
  author={Carlo Albera and Ulrich Costabel and ElizabethA. Fagan and Marilyn K. Glassberg and Eduard Gorina and Lisa H. Lancaster and David J. Lederer and Steven Nathan and Dominique Spirig and Jeff J. Swigris},
  journal={The European respiratory journal},
  year={2016},
  volume={48 3},
  pages={
          843-51
        }
}
This post hoc analysis examined the differences in idiopathic pulmonary fibrosis disease progression and the effects of pirfenidone in patients stratified by more preserved versus less preserved baseline lung function status using forced vital capacity (FVC) or GAP (gender, age and physiology) index stage.Efficacy outcomes, i.e. FVC, 6-min walking distance (6MWD) and dyspnoea (University of California San Diego Shortness of Breath Questionnaire (UCSD SOBQ)), were analysed at 12 months in… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 22 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 29 REFERENCES

Similar Papers

Loading similar papers…